BOEHRINGER INGELHEIM
Boehringer Ingelheim is a research-driven group of companies dedicated to researching, developing, manufacturing, and marketing pharmaceuticals that improve health and quality of life. Our businesses comprise Prescription Medicine, Animal Health, and Biopharmaceuticals.
BOEHRINGER INGELHEIM
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1885-01-01
Address:
Ingelheim Am Rhein, Rheinland-Pfalz, Germany
Country:
Germany
Website Url:
http://www.boehringer-ingelheim.com
Total Employee:
10001+
Status:
Active
Contact:
+49 - 6132 - 770
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving Wordpress Plugins
Similar Organizations
AOP Orphan Pharmaceuticals
AOP Orphan Pharmaceuticals engages in developing, marketing, and distributing medicines for orphan indications and complex diseases.
Avacta Animal Health
Avacta Animal Health is an veterinary laboratory service provider and diagnostic tester to surgeons, laboratories on animal allergies.
Boehringer Mannheim
Boehringer Mannheim is a Germany-based maker of drugs and diagnostic products.
Mayne Pharma
Mayne Pharma Group, a specialist pharmaceutical company, optimizes and delivers oral drugs.
Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-06-15 | Trutino Biosciences | Trutino Biosciences acquired by Boehringer Ingelheim | N/A |
| 2021-09-21 | Abexxa Biologics | Abexxa Biologics acquired by Boehringer Ingelheim | N/A |
| 2020-12-10 | NBE-Therapeutics | NBE-Therapeutics acquired by Boehringer Ingelheim | 1.18 B EUR |
| 2020-12-09 | Labor Dr. Merk & Kollegen | Labor Dr. Merk & Kollegen acquired by Boehringer Ingelheim | N/A |
| 2020-07-27 | Global Stem cell Technology | Global Stem cell Technology acquired by Boehringer Ingelheim | N/A |
| 2020-05-14 | Northern Biologics Inc. | Northern Biologics Inc. acquired by Boehringer Ingelheim | N/A |
| 2019-07-15 | Amal Therapeutics | Amal Therapeutics acquired by Boehringer Ingelheim | 325 M EUR |
| 2019-03-29 | ICD Therapeutics | ICD Therapeutics acquired by Boehringer Ingelheim | N/A |
| 2018-09-13 | Vira Therapeutics | Vira Therapeutics acquired by Boehringer Ingelheim | 245 M USD |
| 2017-01-01 | Merial Limited | Merial Limited acquired by Boehringer Ingelheim | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-09-11 | Click Therapeutics | Boehringer Ingelheim investment in Funding Round - Click Therapeutics | 500 M USD |
| 2020-07-31 | Proxygen | Boehringer Ingelheim investment in Grant - Proxygen | N/A |
| 2020-01-10 | NBE-Therapeutics | Boehringer Ingelheim investment in Series C - NBE-Therapeutics | 22 M USD |
| 2018-07-09 | MabVax Therapeutics | Boehringer Ingelheim investment in Post-IPO Equity - MabVax Therapeutics | 11 M USD |
| 2018-01-01 | Greybox Solutions | Boehringer Ingelheim investment in Series A - Greybox Solutions | N/A |
| 2014-11-25 | Promethera Biosciences | Boehringer Ingelheim investment in Series C - Promethera Biosciences | 25.3 M EUR |
Newest Events participated
Official Site Inspections
http://www.boehringer-ingelheim.com Semrush global rank: 112.74 K Semrush visits lastest month: 847.37 K
- Host name: 45.60.242.221
- IP address: 45.60.242.221
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Boehringer Ingelheim"
About Us | Boehringer Ingelheim CA
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the financial highlights, the corporate vision, the organization, the Board of Managing Directors, and the company's …See details»
Our Company - Boehringer Ingelheim A Family Owned …
As a family-owned company Boehringer Ingelheim is governed by the Board of Managing Directors composed of six members. Read more about their respective responsibilities. Read more European Election: Europe needs our vote …See details»
Home | Boehringer Ingelheim
Boehringer Ingelheim's holistic approach could revolutionize diabetic eye care, preventing vision loss and preserving the gift of sight. ... Discover how the launch of Boehringer Ingelheim …See details»
Boehringer Ingelheim - Wikipedia
• 1885: Albert Boehringer buys a small tartar factory in Ingelheim am Rhein; work begins on 1 August. • 1886: The factory commences production of tartaric acid for use in the food industry (e.g. in baking powder and carbonated beverages). • 1893: Albert Boehringer renames the company C. H. Boehringer Sohn (CHBS) after his father, Christoph Heinrich Boehringer. See details»
PAGE 10–48 GROUP MANAGEMENT REPORT - Boehringer Ingelheim
Boehringer Ingelheim has stood for innovation for over 135 years. The Group is among the world’s 20 leading companies in this sector. Founded in 1885, the family-owned company with …See details»
Annual Report 2022 - Boehringer Ingelheim
Innovation drives us at Boehringer Ingelheim as we strive to positively impact lives of humans and animals with our innovative solutions. In 2022 we were able to help more people than ever before. ... How Boehringer Ingelheim uses …See details»
Boehringer Ingelheim - Leadership Team - The Org
The Leadership Team at Boehringer Ingelheim is responsible for steering the company towards its mission of enhancing patient care through innovative solutions. Comprising top executives …See details»
Boehringer Ingelheim - The Org
At Boehringer Ingelheim they create value through innovation with one clear goal: to improve the lives of patients. They develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both …See details»
Boehringer Ingelheim (Canada) Ltd. | Arthritis Society Canada
Boehringer Ingelheim employs approximately 600 people across Canada. More information about Boehringer Ingelheim can be found at www.boehringer-ingelheim.ca or in our annual report ...See details»
Org Chart Boehringer Ingelheim - The Official Board
The organizational chart of Boehringer Ingelheim displays its 81 main executives including Hubertus von Baumbach, Carinne Brouillon and Jan Visser. Toggle navigation The Official Board. Search. Search. Search by segment. Sign In. …See details»
Corporate Profile | Boehringer Ingelheim CA
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company …See details»
Orchestrating a global pharmaceutical supply chain - Boehringer …
Demand forecasting at Boehringer Ingelheim’s Human Pharma business is based on data drawn from all regions and countries it serves. The supply chain team then works with experts from …See details»
We are open science | Boehringer Ingelheim Open Innovation Portal
My collaboration with Boehringer Ingelheim, mediated by its open innovation portal opnMe, has provided us with access to unique reagents and resources and enabled rapid progress over …See details»
Boehringer Ingelheim increases commitments to ... - Business Wire
Oct 25, 2021 In 2020 a new pilot program was launched in Pakistan in collaboration with the World Organization for Animal Health (OIE) to eliminate rabies by donating Boehringer …See details»
About Us | Biopharmaceuticals - Boehringer Ingelheim
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the financial highlights, the corporate vision and the organization. …See details»
Company Culture - Boehringer Ingelheim
Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products. Section …See details»
Annual Report 2022 - Boehringer Ingelheim
In my region, Boehringer Ingelheim has launched an initiative called B-Effect. Our theme for this year is to create awareness about reducing the use of disposable plastic. Globally, the …See details»
Global Medical Affairs Learning, Training, Coaching Lead
If you have any questions about the job posting or process - please contact our HR Direct Team, Tel: +49 (0) 6132 77-3330 or via mail: [email protected]. Please, add a short …See details»
Annual Report 2022 - Boehringer Ingelheim
That includes Boehringer Ingelheim, whose new Global Computational Biology and Digital Sciences department (gCBDS) is harnessing data for the benefit of drug discovery. “We want …See details»
Corporate Profile | Boehringer Ingelheim CA
At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health. As a successful, family owned company we plan in generations. We work …See details»